They will fix a shorter or longer beyond-use date
Lancet Diabetes Endocrinol 5(4):271279 Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF, STEP 1 Study Group (2022) Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
But as Medicaid spending rises, its likely there will be calls to move faster toward a full Medicaid managed care system
Multiple 503B facilities continue to produce compounded semaglutide under various legal theories, including active court orders that prevent the FDA from enforcing certain restrictions